Brain tumours: when a headache, memory lapse, or seizure deserves a second look
Following the observance of World Brain Day on July 22 , it is vital to recognise that timely diagnosis and multidisciplinary care can make a significant difference in not only survival, but also in long-term recovery and quality of life for patients and their families.
When the body whispers
Brain tumours are complex. They vary in type, location, and behaviour—and so do their symptoms. In clinical practice, I often see patients who, in hindsight, experienced signs long before their diagnosis. These early symptoms are frequently dismissed as benign issues: a tension headache, forgetfulness, vision strain, or clumsiness.
Common symptoms of brain tumours include:
Persistent or worsening headaches
Memory lapses or personality changes
Difficulty in speaking or finding words
Blurred or double vision
New-onset seizures
Trouble with balance or coordination
It is important to understand that many of these symptoms—particularly headaches, giddiness, or occasional forgetfulness—are very common and more often than not due to benign conditions like migraines, tension headaches, or positional vertigo. Not every headache warrants a brain scan. However, when these symptoms are unusual in pattern, progressively worsening, or accompanied by other neurological signs, a medical evaluation is essential.
The key challenge is that these symptoms can appear mild or sporadic, leading to delays in seeking medical attention. But when the brain is affected—even subtly—it often tries to signal distress. We need to listen more closely.
Children are not immune
One of the most overlooked realities is that brain tumours affect children too. Among paediatric populations, tumours in the cerebellum—such as medulloblastoma—are relatively common. The signs, however, may not always be easy to spot.
In children, red flags include:
Headaches, especially in the morning
Repeated vomiting without a clear cause
Unsteady gait or difficulty walking
Clumsiness or frequent falls
Unlike adults, children may not articulate their discomfort clearly. A parent's intuition, in such cases, becomes crucial. Prompt neurological evaluation can lead to early diagnosis and treatment, which significantly improves outcomes. With timely surgery, radiation, chemotherapy, and structured rehabilitation, many children not only survive but go on to live full, healthy adult lives.
The ripple effects of a brain tumour
The impact of a brain tumour extends far beyond the individual. It disrupts family dynamics, imposes financial burdens, and creates emotional strain for caregivers. It can affect workplace productivity and community engagement. That is why recovery must be viewed not just through a medical lens but a social one.
When treated early, many patients return to school, work, and community life. The difference lies in how quickly the tumour is recognised and how comprehensively it is managed.
The power of modern tools and teamwork
Neuro-oncology teams use a suite of advanced tools designed to enhance precision and safety: neuronavigation systems function like GPS during surgery, guiding the surgeon with remarkable accuracy. High-resolution operating microscopes allow us to see deep brain structures clearly. Awake craniotomy enables patients to stay awake during surgery to protect speech and movement centres. Intraoperative neurophysiological monitoring helps preserve critical brain functions during complex procedures. Comprehensive post-operative rehabilitation ensures that recovery continues well beyond the operating room.
These innovations help us safely access delicate regions of the brain while preserving the patient's independence and cognitive function.
A realistic, hopeful outlook
While early detection improves prognosis, it is important to acknowledge that not all brain tumours behave predictably. Some aggressive tumours may resist treatment even when diagnosed early. Others may lie dormant and symptom-free for extended periods. That said, the opportunity for meaningful intervention exists at nearly every stage.
Whether through surgical removal, chemotherapy, radiation, or supportive therapies, modern neuro-oncology offers real hope—particularly when treatment is tailored to the individual.
Brain tumours don't always present dramatically. They may arrive disguised as a persistent headache, an uncharacteristic lapse in memory, or a subtle speech difficulty. In children, they may be hidden behind a morning vomit or a minor fall. These are not signs to ignore.
This World Brain Day, let us renew our commitment to awareness and early action. By paying attention to the whispers, we can catch the signs sooner, act faster, and improve the lives of those affected. Because sometimes, listening to the smallest signals leads to the biggest differences.
(Dr. Komal Prasad C. is a senior consultant – neurosurgery, Narayana Health City, Bengaluru. drkomalprasad@gmail.com)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
4 hours ago
- Mint
Why you need to go easy with your protein- snacking
Protein mania moved beyond the gyms and fitness world a long time ago. Today, everyone, irrespective of whether they workout or not, talks about protein. It is a favourite conversation starter in social situations and even children aren't safe anymore as parents invariably ask their young ones, 'What protein did you eat?" With healthy snacks—from protein chips and protein lassi to protein ice cream and protein popcorn — all around us, snacking for comfort or joy is frowned upon. But if that wasn't enough, a protein beer, believe it or not, has just been launched. Yes, a nutrition company has actually made a beer with 5 grams of protein and 0.5 percent of alcohol per can. This shows how irrational our current focus on protein has become. 'In many ways, protein has gone from being a fundamental nutrient to a trendy product. While awareness about protein is important, the marketing has blurred the line between genuine health needs and consumerism. Not every snack needs to be 'protein-fortified" to be considered healthy," says Pooja Udeshi, a sports nutrition consultant at the Kokilaben Dhirubhai Ambani Hospital in Mumbai. According to the Indian Council of Medical Research (ICMR) and National Institute of Nutrition (NIN), the estimated average requirement for protein intake is 0.66 gram of protein per kilogram of bodyweight per day for healthy men and women while the recommended dietary allowance for protein intake is 0.88 gram of protein per kilogram of bodyweight per day for healthy men and women. In their latest Dietary Guidelines for Indians released in 2024, ICMR and NIN note that the daily diet of an adult often 'provides 60 grams to 70 grams of protein a day, which is higher than what we require." Besides muscle and strength building, proteins are needed for functions such as providing energy, making enzymes, hormones, cell membranes, carrying oxygen to tissues, and replacing damaged or worn out tissues. 'Protein is not just a gym nutrient. It's a daily necessity for all body systems," says Udeshi. Protein has always been an essential nutrient for everyone, but it wasn't always the centre of attention. The only people who used to talk about protein were gym-goers whose trainers would encourage them to increase their dietary protein intake. But things changed when the covid-19 pandemic hit. 'The pandemic made people more aware about their health, particularly around immunity, fitness, and weight control. With gyms closed and routines disrupted, there was a sharp rise in home workouts and fitness influencers, many of whom pushed protein supplements as essential for muscle maintenance, fat loss, and energy," explains Madhura Paroolkar Behki, head nutritionist and dietician at Cult Fit. Social media amplified this and protein became symbolic of a fit lifestyle, adds Udeshi. DO WE NEED TO CONSUME SO MUCH PROTEIN? Today, with more people becoming health conscious, protein is synonymous with better health. 'Consumers are increasingly equating high protein with 'healthy,' which isn't always true, especially because many of these protein products are ultra-processed or high in sugar and fat. Protein is important, but the everything-must-be-high-protein trend risks diluting the public understanding of overall nutrition. This shift is morphing from awareness to commercial overuse," warns Behki. A recent crowd-funded healthcare initiative called The Citizens Protein Project 2 conducted an exhaustive analysis and lab tests on whey protein supplements marketed in India and found that 38% protein powders marketed by pharmaceutical companies and 25% of those marketed by nutraceutical companies contained heavy metals such as lead, arsenic, cadmium and mercury, many contained fungal toxins, steroids, progesterone hormone and added sugars including sucrose and fructose. More crucially, a majority of the people do not even need these protein snacks and supplements in the first place. 'For the average person with a balanced diet and moderate activity, supplements aren't necessary. And, for those not exercising at all, excess protein won't magically build muscle or boost metabolism. That's a myth," says Udeshi. In fact, consistently over-consuming protein (especially from processed foods/supplements) can stress the kidneys over time, warns Behki. While on the topic of protein intake, one widespread misconception is that those on vegetarian and vegan diets struggle to meet their protein requirements through a regular diet. 'While non-vegetarians have it easier with eggs, chicken and fish, vegetarians can get enough protein with smart food planning. They can rely on dals, legumes, dairy, tofu, tempeh, nuts, seeds, and whole grains," says Udeshi. Behki adds that it's important for both vegetarians and non-vegetarians to ensure that some protein is added in every meal of the day to meet the set requirements. 'Eggs, fish and lean meats are good sources of complete proteins while vegetarian foods such as soya, tofu, dairy products, lentils and legumes are high in protein," says Behki. The ICMR and NIN guidelines also point out that while meat, poultry and fish are very good sources of good quality protein, those on a vegetarian diet can get the requisite amount of protein from an appropriate combination of three parts of cereals with one part of pulses. As for those who exercise regularly, especially strength or endurance training, protein supplements can help, more so in cases where dietary intake is insufficient. Whey, casein, or plant-based protein powders are convenient and can support muscle repair and growth. But even these active people do not need protein snacks such as protein popcorn, protein yogurt or protein beer. It is best to give these protein snacks a wide berth as these are often ultra-processed, expensive, and, sometimes, don't even contain high quality protein. 'Being fit or healthy isn't about 'protein snacking'. It's about consistent habits, real food, movement, and rest," says Behki. Shrenik Avlani is a writer and editor and the co-author of The Shivfit Way, a book on functional fitness.
The Hindu
7 hours ago
- The Hindu
How far have we come in providing personalised radiation treatment for cancer patients?
Radiotherapy, also known as radiation oncology or radiation therapy, is an important arm of cancer therapy. It involves the use of high-energy ionizing radiation to predominantly treat malignancies, as well as certain benign conditions. In India, due to lack of awareness and inadequate cancer screening initiatives, a majority of cancer patients seek medical help when the disease is locally advanced, and hence are candidates requiring multi-modality treatment including various combinations of surgery, radiotherapy, chemotherapy, biological therapy and immunotherapy. Nearly 70% of cancer patients need radiotherapy as a part of their cancer treatment protocol, where its role may be a primary curative treatment, additional or adjunct treatment or palliative therapy to relieve symptoms in advanced disease stages. Also Read: ICMR study finds only 28.5% of cancer patients receive radiotherapy in India Understanding radiotherapy There are 2 primary treatment modalities in radiotherapy: teletherapy or external beam radiotherapy and brachytherapy. In the former, the patient is placed at a distance from the radiation-generating equipment (generating high-energy x rays or gamma radiation) and by virtue of the beam divergence, a homogenous dose is delivered to the tumour tissue. In brachytherapy, radiation-emitting radioactive sources are directly placed in contact with the tumour tissue and subsequently removed after a specific period of time, thereby delivering a high dose to the tumour directly. The last two decades have seen significant strides in the field of radiation oncology. Technological developments in hardware and software industries have led to development of equipment enabling high precision radiation delivery with sub-millimetre accuracy, resulting in better tumour control and reduction in treatment-related side effects arising out of damage to normal tissues adjacent to the tumour. Until a few years ago, access to this high precision radiotherapy treatment was restricted to large metropolitan cities. With the active involvement of government health agencies (both at the Centre and State levels) along with public private partnerships, there is currently a focussed attempt to reduce this disparity and improve the availability of radiotherapy treatment at most district-level hospitals. Contemporary radiotherapy treatment Contemporary high precision radiotherapy treatment techniques such as Intensity modulated radiotherapy (IMRT), Image Guided Radiotherapy (IGRT), Volumated Arc therapy (VMAT/Rapid Arc), Stereotactic Radiosurgery and Stereotactic Radiotherapy (SRS and SRT), have enabled treatment of cancer tissues with higher radiation doses and with preferential sparing of normal tissue. These techniques have also enabled the feasibility of organ preservation in daily practice. In spite of these benefits, all cancer patients undergoing radiotherapy do not get cured of cancer. An important limitation of present-day cancer treatment, including radiation therapy, is that the response of a tumour to treatment varies from person to person ranging from complete response to partial response and in some cases, disease progression despite treatment. This is due to differences in the genetic and protein composition of the tumours which varies from patient to patient and which can influence treatment outcomes. Another important limitation is treatment-related side effects, which vary from patient to patient and can interfere with treatment compliance necessitating lifestyle modifications during, and post treatment. In simple terms 'one size does not fit all'. Although the prescribed radiotherapy treatment might be the global established standard of care for a particular disease condition and stage, individual variations in treatment response and tolerance are the norm, which cannot currently be predicted based on any assessment tool. While available radiotherapy guidelines are mainly based on the average response of disease population to treatment, this approach fails to account for individual tumour variations with respect to their molecular and genetic signature as well as patient heterogeneity with respect to their demography, genetic makeup and pattern of lifestyle. There is an unmet need to develop markers which can predict or identify non-responders to radiation and those patients who are likely to develop disease progression while on treatment. There is also an urgent need to identify patients who are likely to suffer significant toxicity and discontinue treatment. In this regard, there exists an unmet need to develop drugs which can reduce radiation- related toxicity without interfering with the radiation's anti-tumour capabilities. Can newer tech such as proton therapy solve the problem? The introduction of proton therapy in India along with its dosimetric capability of delivering radiation doses only at a particular range of depth within the patient's body, has significantly reduced early and late complications of radiotherapy with the latter being an important advantage in treatment of paediatric patients. But proton therapy is not a personalised radiotherapy solution and patients can still have residual disease or recurrent disease after proton therapy, based on the radiosensitivity of the tumour. Also, the limited availability of proton therapy presently in India and the high cost of treatment are other inherent issues that render it as a non-viable treatment solution for a majority of Indian patients who cannot afford the cost. Thus there is an inherent need for developing personalised radiotherapy treatment practises which can allow a physician to predict the possible treatment response and risk of recurrence of a particular disease based on its molecular and genetic composition. Such a personalised radiotherapy protocol would have the following advantages in that it can: Provide optimal radiation treatment tailored to each patient tumour's unique biological and clinical characteristics Predict tumour response to radiotherapy prior to initiation of treatment thereby avoiding treatment- related toxicity in potential non-responders Then the pertinent question which arises is whether such a personalised radiotherapy protocol or assessment tool is in existence or whether it can be developed? The answer is a resounding yes. The promise of research into genetics and AI In recent years, probing research in the field of molecular oncology, genetics and artificial intelligence (AI) are bringing the concept of personalized radiotherapy closer to actual realization. At one end, data-driven AI and deep learning models are being developed to identify predictors of radiation sensitivity. This information is being gathered by accessing huge quantities of data regarding tumour behaviour and their associated pathological and molecular characteristics collected over the years, and corelating them with the outcomes of radiotherapy treatment already delivered. The following areas of medical research are contributing in a big way to the development of personalised radiotherapy treatment in the near future. These include – Digital pathology – This involves acquisition and interpretation of pathology information in digital format and environment. This, in turn, improves rapid referral of cases between hospitals and doctors for expert opinions or second opinions and facilitates incorporation of digital training resources into pathology reporting, paving the way for integration of AI in pathological reporting. Radiomics in prognostication – This involves analysis of certain patterns and disease characteristics from radiological scans, and the use of this information to predict patient outcomes and treatment responses to cancer. Radiomics aims to provide more precise information to guide treatment decisions. Genomics and proteomics-based treatment decisions – The development of bioinformatics and its integration with tumour-related genetics and molecular information is being used to develop genomic and proteomic-based tumour biology panels, which can help in early diagnosis as well as predict response to treatment. This can lead to more personalised and effective cancer treatment strategies. AI-based adaptive radiotherapy – A revolutionary concept in radiotherapy, this involves the use of AI-based tools to analyse tumour-related changes during a course of radiotherapy. In adaptive RT, before a patient receives his scheduled daily radiotherapy treatment, he is subjected to a CT scan or MR images which are acquired on the radiotherapy machine, prior to treatment. These images acquired are interpreted by AI-based programmes, which then calculate changes in tumour geometry based on daily radiation response. The radiation plan is then altered real time, and adjusted on a daily basis to effectively target the tumour and reduce damage to healthy tissues. This approach enhances the therapeutic ratio of the treatment, potentially improving cure rates while minimising side effects. One other area of research which is going to influence personalised radiotherapy services positively, is work on nanoparticle technology, which can enable a higher concentration of drugs delivered directly inside the tumour or its related microenvironment thereby increasing radiotherapy associated tumour damage and minimising normal tissue damage. AI-driven assessment of oral and gastrointestinal microbiome changes in response to radiotherapy are also being assessed as a prognostic tool to predict radiation responses. Another important development is research aimed at integrating daily PET CT scans into adaptive radiotherapy (biological adaptive RT), which adds functional information of the treatment along with anatomical data to refine adaptive radiotherapy plans. Although a lot of research efforts are currently underway in multi-directional fields with a single-minded focus on enabling personalised cancer treatment strategies, a lot of validation needs to be further done in this regard to enable these modalities to be incorporated into daily treatment protocols. However, the good news is that we have indeed covered a lot of ground in realising this dream and the day is not far when the concept of personalised radiotherapy will be translated from the laboratory bench to bedside practise. (Dr. K. Satish Srinivas is professor and head of the department of radiation oncology, SRIHER, Chennai.
Hindustan Times
11 hours ago
- Hindustan Times
Orthopaedic doctor says ‘adding probiotics to your diet can help control joint arthritis, joint pain': Here's how
Probiotics are live microorganisms (microbes) that can have beneficial effects on or inside your body. Most popularly, consuming probiotic foods and supplements is known to have a beneficial effect on your gut health. But did you know they can also help control arthritis in your joints? Having probiotics and an anti-inflammatory diet can control your gut-joint axis and prevent or control the rate of progression of arthritis. (Shutterstock) Also Read | Gastroenterologist shares top 10 spices and herbs that your gut loves: From haldi to cinnamon and ajwain In a post shared on June 4, Dr Tushar Gupta, MCh joint replacement and arthroscopy (AIIMS), MBBS, MS Orthopaedics, talked about the importance of consuming probiotics on joint health. Sharing the video, the orthopaedic doctor wrote, 'Probiotics treat arthritis.' How does eating probiotics help with joint arthritis? The orthopaedic expert stated in the Instagram video that adding probiotics to your diet can help you control your joint arthritis. He explained, 'Having probiotics and an anti-inflammatory diet can control your gut-joint axis and prevent or control the rate of progression of arthritis. These dietary substances can modulate gut bacteria, leading to a healthier bloodstream and decreased inflammation throughout your body. They can also help control your joint-related pain.' Which probiotics are effective? According to the Cleveland Clinic, for a probiotic to have any benefit to your health, it must: Be of a variety that has proven benefits for your body. Be in a form that's safe to consume or apply to your body. Contain viable microbes that have survived the commercial process. Be able to survive the journey through your digestive tract (if it's an oral probiotic). Surprising probiotic foods found in Indian kitchens In an interview with HT Lifestyle, AIIMS and ICMR-trainer Pariksha Rao, Director - nutrition and medical affairs, The Good Bug, shared a list of probiotic-rich foods found in our Indian kitchens. Here are a few examples: Paneer Idlis and dosas Chaas (Buttermilk) Pickles (Achaar) Kanji Dhokla Gundruk and panta bhat Sol kadhi Green peas and beetroot Apples and whole wheat bread: Rich in both probiotics and dietary fibre. Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
